News
05-16-2018, 07:43 PM
In a recent study published in the Journal of Clinical Investigation, Mayo Clinic researchers identified that an FDA drug approved for myelodysplastic syndrome may be useful to treat triple-negative breast cancer, which is one of the most aggressive and lethal types of breast cancer.
More... (https://www.news-medical.net/news/20180516/Mayo-Clinic-researchers-identify-new-possible-treatment-choice-for-triple-negative-breast-cancer.aspx)
More... (https://www.news-medical.net/news/20180516/Mayo-Clinic-researchers-identify-new-possible-treatment-choice-for-triple-negative-breast-cancer.aspx)